Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: Role of IGF-2

Journal of Neuroimmunology

Volumn 227, Issue 1-2, 2010, Pages 71-79

  Zhang, Y ^a   Jalili, F ^b   Ouamara, N ^b   Zameer, A ^a   Cosentino, G ^b   Mayne, M ^c   Hayardeny, L ^d   Antel, J P ^b   Bar Or, A ^b   John, G R ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b MCGILL UNIVERSITY   (Canada)

^c UNIVERSITY OF MANITOBA   (Canada)

^d TEVA PHARMACEUTICALS   (Israel)

Author keywords

CNS repair; Glatiramer acetate; Multiple sclerosis; Oligodendrocyte progenitor; T lymphocyte

Indexed keywords

2',3' CYCLIC NUCLEOTIDE 3' PHOSPHODIESTERASE; BONE MORPHOGENETIC PROTEIN 4; CXCL1 CHEMOKINE; CXCL3 CHEMOKINE; FIBROBLAST GROWTH FACTOR 1; FOLLISTATIN; GLATIRAMER; GLIAL FIBRILLARY ACIDIC PROTEIN; LEUKEMIA INHIBITORY FACTOR; OKT 3; OLIGODENDROCYTE TRANSCRIPTION FACTOR 2; OSTEOGENIC PROTEIN 1; SOMATOMEDIN B; IMMUNOLOGICAL ADJUVANT; PEPTIDE;

ANIMAL CELL; ARTICLE; CELL COUNT; CELL DIFFERENTIATION; CELL LINEAGE; CELL POLARITY; CONTROLLED STUDY; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; NERVE CELL CULTURE; NONHUMAN; OLIGODENDROCYTE PROGENITOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; STEM CELL; T LYMPHOCYTE ACTIVATION; TH1 CELL; TH2 CELL; ANIMAL; CELL CULTURE; CELL PROLIFERATION; COMPARATIVE STUDY; CYTOLOGY; DRUG EFFECTS; IMMUNOLOGY; LYMPHOCYTE COUNT; MOUSE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; PATHOLOGY; PHYSIOLOGY; PROCEDURES; TUMOR CELL LINE;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; CELL LINE, TUMOR; CELL LINEAGE; CELL PROLIFERATION; CELLS, CULTURED; HUMANS; INSULIN-LIKE GROWTH FACTOR II; LYMPHOCYTE COUNT; MICE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; OLIGODENDROGLIA; PEPTIDES; STEM CELLS; TH2 CELLS;

EID: 77956649226     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.06.014     Document Type: Article

References (54)

1. Aharoni R., Teitelbaum D., Sela M., Arnon R. Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis. Proc. Natl. Acad. Sci. U. S. A. 1997, 94:10821-10826.
2. Aharoni R., Teitelbaum D., Sela M., Arnon R. Bystander suppression of experimental autoimmune encephalomyelitis by T cell lines and clones of the Th2 type induced by copolymer 1. J. Neuroimmunol. 1998, 91:135-146.
3. Aharoni R., Eilam R., Domev H., Labunskay G., Sela M., Arnon R. The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:19045-19050.
4. Arnon R., Aharoni R. Mechanism of action of glatiramer acetate in multiple sclerosis and its potential for the development of new applications. Proc. Natl. Acad. Sci. U. S. A. 2004, 101(Suppl 2):14593-14598.
5. Barres B.A., Schmid R., Sendnter M., Raff M.C. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development 1993, 118:283-295.
6. Bieber A.J., Kerr S., Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann. Neurol. 2003, 53:680-684.
7. Blanchette F., Neuhaus O. Glatiramer acetate: evidence for a dual mechanism of action. J. Neurol. 2008, 255(Suppl 1):26-36.
8. Bruck W., Kuhlmann T., Stadelmann C. Remyelination in multiple sclerosis. J. Neurol. Sci. 2003, 206:181-185.
9. Butzkueven H., Zhang J.G., Soilu-Hanninen M., Hochrein H., Chionh F., Shipham K.A., Emery B., Turnley A.M., Petratos S., Ernst M., Bartlett P.F., Kilpatrick T.J. LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat. Med. 2002, 8:613-619.
10. Caporaso G.L., Chao M.V. Telomerase and oligodendrocyte differentiation. J. Neurobiol. 2001, 49:224-234.
11. Carson M.J., Behringer R.R., Brinster R.L., McMorris F.A. Insulin-like growth factor I increases brain growth and central nervous system myelination in transgenic mice. Neuron 1993, 10:729-740.
12. Chen M., Conway K., Johnson K.P., Martin R., Dhib-Jalbut S. Sustained immunological effects of Glatiramer acetate in patients with multiple sclerosis treated for over 6years. J. Neurol. Sci. 2002, 201:71-77.
13. Chen M., Valenzuela R.M., Dhib-Jalbut S. Glatiramer acetate-reactive T cells produce brain-derived neurotrophic factor. J. Neurol. Sci. 2003, 215:37-44.
14. Cui G., Zhang Y., Gong Z., Zhang J.Z., Zang Y.Q. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes. Cell Res. 2009, 19:574-583.
15. Dhib-Jalbut S., Chen M., Said A., Zhan M., Johnson K.P., Martin R. Glatiramer acetate-reactive peripheral blood mononuclear cells respond to multiple myelin antigens with a Th2-biased phenotype. J. Neuroimmunol. 2003, 140:163-171.
16. Eisen M.B., Spellman P.T., Brown P.O., Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:14863-14868.
17. Foote A.K., Blakemore W.F. Inflammation stimulates remyelination in areas of chronic demyelination. Brain 2005, 128:528-539.
18. Fridkis-Hareli M., Strominger J.L. Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules. J. Immunol. 1998, 160:4386-4397.
19. Fridkis-Hareli M., Neveu J.M., Robinson R.A., Lane W.S., Gauthier L., Wucherpfennig K.W., Sela M., Strominger J.L. Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules. J. Immunol. 1999, 162:4697-4704.
20. Gadea A., Schinelli S., Gallo V. Endothelin-1 regulates astrocyte proliferation and reactive gliosis via a JNK/c-Jun signaling pathway. J. Neurosci. 2008, 28:2394-2408.
21. Gao L., Macklin W., Gerson J., Miller R.H. Intrinsic and extrinsic inhibition of oligodendrocyte development by rat retina. Dev. Biol. 2006, 290:277-286.
22. Gran B., Tranquill L.R., Chen M., Bielekova B., Zhou W., Dhib-Jalbut S., Martin R. Mechanisms of immunomodulation by glatiramer acetate. Neurology 2000, 55:1704-1714.
23. Hammarberg H., Lidman O., Lundberg C., Eltayeb S.Y., Gielen A.W., Muhallab S., Svenningsson A., Linda H., van Der Meide P.H., Cullheim S., Olsson T., Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J. Neurosci. 2000, 20:5283-5291.
24. Hsieh J., Aimone J.B., Kaspar B.K., Kuwabara T., Nakashima K., Gage F.H. IGF-I instructs multipotent adult neural progenitor cells to become oligodendrocytes. J. Cell Biol. 2004, 164:111-122.
25. Jee Y., Piao W.H., Liu R., Bai X.F., Rhodes S., Rodebaugh R., Campagnolo D.I., Shi F.D., Vollmer T.L. CD4(+)CD25(+) regulatory T cells contribute to the therapeutic effects of glatiramer acetate in experimental autoimmune encephalomyelitis. Clin. Immunol. 2007, 125:34-42.
26. Kerschensteiner M., Meinl E., Hohlfeld R. Neuro-immune crosstalk in CNS diseases. Neuroscience 2009, 158:1122-1132.
27. Kim H.J., Biernacki K., Prat A., Antel J.P., Bar-Or A. Inflammatory potential and migratory capacities across human brain endothelial cells of distinct glatiramer acetate-reactive T cells generated in treated multiple sclerosis patients. Clin. Immunol. 2004, 111:38-46.
28. Kim H.J., Ifergan I., Antel J.P., Seguin R., Duddy M., Lapierre Y., Jalili F., Bar-Or A. Type 2 monocyte and microglia differentiation mediated by glatiramer acetate therapy in patients with multiple sclerosis. J. Immunol. 2004, 172:7144-7153.
29. Kotter M.R., Setzu A., Sim F.J., Van Rooijen N., Franklin R.J. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 2001, 35:204-212.
30. Kumar S., Kahn M.A., Dinh L., de Vellis J. NT-3-mediated TrkC receptor activation promotes proliferation and cell survival of rodent progenitor oligodendrocyte cells in vitro and in vivo. J. Neurosci. Res. 1998, 54:754-765.
31. Mayne M., Cheadle C., Soldan S.S., Cermelli C., Yamano Y., Akhyani N., Nagel J.E., Taub D.D., Becker K.G., Jacobson S. Gene expression profile of herpesvirus-infected T cells obtained using immunomicroarrays: induction of proinflammatory mechanisms. J. Virol. 2001, 75:11641-11650.
32. McTigue D.M., Horner P.J., Stokes B.T., Gage F.H. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J. Neurosci. 1998, 18:5354-5365.
33. Miller R.H., Dinsio K., Wang R., Geertman R., Maier C.E., Hall A.K. Patterning of spinal cord oligodendrocyte development by dorsally derived BMP4. J. Neurosci. Res. 2004, 76:9-19.
34. Moalem G., Leibowitz-Amit R., Yoles E., Mor F., Cohen I.R., Schwartz M. Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy. Nat. Med. 1999, 5:49-55.
35. Neuhaus O., Farina C., Yassouridis A., Wiendl H., Then Bergh F., Dose T., Wekerle H., Hohlfeld R. Multiple sclerosis: comparison of copolymer-1-reactive T cell lines from treated and untreated subjects reveals cytokine shift from T helper 1 to T helper 2 cells. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:7452-7457.
36. Neumann H., Kotter M.R., Franklin R.J. Debris clearance by microglia: an essential link between degeneration and regeneration. Brain 2009, 132:288-295.
37. Nicholas R.S., Stevens S., Wing M.G., Compston D.A. Microglia-derived IGF-2 prevents TNFalpha induced death of mature oligodendrocytes in vitro. J. Neuroimmunol. 2002, 124:36-44.
38. Raine, C.S., McFarland, H.F., Tourtellotte, W.W., 1997. Multiple sclerosis: clinical and pathogenic basis. Chapman & Hall Medical, London; New York, pp. xiii, 426 pp.
39. Robinson S., Tani M., Strieter R.M., Ransohoff R.M., Miller R.H. The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J. Neurosci. 1998, 18:10457-10463.
40. Setzu A., Lathia J.D., Zhao C., Wells K., Rao M.S., Ffrench-Constant C., Franklin R.J. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia 2006, 54:297-303.
41. Skihar V., Silva C., Chojnacki A., Doring A., Stallcup W.B., Weiss S., Yong V.W. Promoting oligodendrogenesis and myelin repair using the multiple sclerosis medication glatiramer acetate. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:17992-17997.
42. Stadelmann C., Kerschensteiner M., Misgeld T., Bruck W., Hohlfeld R., Lassmann H. BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells?. Brain 2002, 125:75-85.
43. Trapp B.D., Peterson J., Ransohoff R.M., Rudick R., Mork S., Bo L. Axonal transection in the lesions of multiple sclerosis. N. Engl. J. Med. 1998, 338:278-285.
44. Van Wauwe J.P., De Mey J.R., Goossens J.G. OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties. J. Immunol. 1980, 124:2708-2713.
45. Vick R.S., DeVries G.H. Mitotic potential of adult rat oligodendrocytes in culture. J. Neurosci. Res. 1992, 33:68-74.
46. Weber M.S., Starck M., Wagenpfeil S., Meinl E., Hohlfeld R., Farina C. Multiple sclerosis: glatiramer acetate inhibits monocyte reactivity in vitro and in vivo. Brain 2004, 127:1370-1378.
47. Weber M.S., Hohlfeld R., Zamvil S.S. Mechanism of action of glatiramer acetate in treatment of multiple sclerosis. Neurotherapeutics 2007, 4:647-653.
48. Wilson H.C., Onischke C., Raine C.S. Human oligodendrocyte precursor cells in vitro: phenotypic analysis and differential response to growth factors. Glia 2003, 44:153-165.
49. Wolinsky J.S. The use of glatiramer acetate in the treatment of multiple sclerosis. Adv. Neurol. 2006, 98:273-292.
50. Wu Q., Miller R.H., Ransohoff R.M., Robinson S., Bu J., Nishiyama A. Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant. J. Neurosci. 2000, 20:2609-2617.
51. Yan H., Wood P.M. NT-3 weakly stimulates proliferation of adult rat O1(-)O4(+) oligodendrocyte-lineage cells and increases oligodendrocyte myelination in vitro. J. Neurosci. Res. 2000, 62:329-335.
52. Zhang Y., Taveggia C., Melendez-Vasquez C., Einheber S., Raine C.S., Salzer J.L., Brosnan C.F., John G.R. Interleukin-11 potentiates oligodendrocyte survival and maturation, and myelin formation. J. Neurosci. 2006, 26:12174-12185.
53. Zhang Y., Argaw A.T., Gurfein B.T., Zameer A., Snyder B.J., Ge C., Lu Q.R., Rowitch D.H., Raine C.S., Brosnan C.F., John G.R. Notch1 signaling plays a role in regulating precursor differentiation during CNS remyelination. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:19162-19167.
54. Ziemssen T., Kumpfel T., Klinkert W.E., Neuhaus O., Hohlfeld R. Glatiramer acetate-specific T-helper 1- and 2-type cell lines produce BDNF: implications for multiple sclerosis therapy. Brain-derived neurotrophic factor. Brain 2002, 125:2381-2391.